Literature DB >> 35023107

Genetic Pathways Involved in the Pathogenesis of Parkinson's Disease.

Konstantina Skolariki1, Marios Diamantopoulos2, Panayiotis Vlamos2.   

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease. PD pathogenesis includes both genetic and environmental factors. Previous studies have linked the disease with several genes such as Parkin, SNCA, PINK1 and HTRA2. BiNGO software utilizes GO annotations in order to detect over-represented genes in terms of biological processes, cellular components and molecular functions. Three databases were utilized for this study (Ensembl, DisGeNET and UniProt). Data processing provided 110 genes associated with PD for further analysis. The aim of this study was to identify genes associated with PD and perform a functional enrichment analysis. Cytoscape and BiNGO software analysis presented several new genes that could play a potential role in pathogenesis of the disease. Future steps include additional research in order to establish the exact mechanism of action of these genes and pathways on PD.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  BiNGO; Cytoscape; Functional enrichment analysis; Gene network; Genetic component; Parkinson’s disease

Mesh:

Substances:

Year:  2021        PMID: 35023107     DOI: 10.1007/978-3-030-78787-5_25

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  39 in total

Review 1.  Axon degeneration in Parkinson's disease.

Authors:  Robert E Burke; Karen O'Malley
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

Review 2.  Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness.

Authors:  Domenico Cieri; Marisa Brini; Tito Calì
Journal:  Biochem Biophys Res Commun       Date:  2016-08-28       Impact factor: 3.575

Review 3.  The role of oxidative stress in Parkinson's disease.

Authors:  Vera Dias; Eunsung Junn; M Maral Mouradian
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

Review 4.  Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement.

Authors:  Alberto J Espay; Peter A LeWitt; Horacio Kaufmann
Journal:  Mov Disord       Date:  2014-10-09       Impact factor: 10.338

5.  Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease.

Authors:  A Fernandez; M L de Ceballos; S Rose; P Jenner; C D Marsden
Journal:  Brain       Date:  1996-06       Impact factor: 13.501

6.  Insulin-like growth factor-I mediates neuroprotection in proteasome inhibition-induced cytotoxicity in SH-SY5Y cells.

Authors:  Benxu Cheng; Shivani Kaushal Maffi; Alex Anthony Martinez; Yolanda P Villarreal Acosta; Liza D Morales; James L Roberts
Journal:  Mol Cell Neurosci       Date:  2011-04-23       Impact factor: 4.314

7.  3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.

Authors:  William J Burke; Shu Wen Li; Evelyn A Williams; Randal Nonneman; Daniel S Zahm
Journal:  Brain Res       Date:  2003-11-07       Impact factor: 3.252

8.  The parkinson's disease-associated LRRK2 mutation R1441G inhibits neuronal differentiation of neural stem cells.

Authors:  Lamia'a Bahnassawy; Sarah Nicklas; Thomas Palm; Ingeborg Menzl; Fabian Birzele; Frank Gillardon; Jens C Schwamborn
Journal:  Stem Cells Dev       Date:  2013-05-24       Impact factor: 3.272

9.  Polymorphisms of DRD2 and DRD3 genes and Parkinson's disease: A meta-analysis.

Authors:  Dongjun Dai; Yunliang Wang; Lingyan Wang; Jinfeng Li; Qingqing Ma; Jianmin Tao; Xingyu Zhou; Hanlin Zhou; Yi Jiang; Guanghui Pan; Limin Xu; Ping Ru; Danfeng Lin; Jun Pan; Leiting Xu; Meng Ye; Shiwei Duan
Journal:  Biomed Rep       Date:  2014-01-13

Review 10.  The Search for Environmental Causes of Parkinson's Disease: Moving Forward.

Authors:  Honglei Chen; Beate Ritz
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.